throbber
No. 7 • December 2007
`
`Contents
`
`Alsiano
`Pharma & Healthcare News
`Evonik-Degussa expands its
`cooperation with Alsiano
`Alsiano new distributor of Evonik Degussa
`AEROSIL® products in Sweden for pharmaceutical
`and healthcare
`
`Evonik-Degussa expands
`its cooperation with
`Alsiano .................................... 1
`
`Healthy South African
`plant extracts from
`Afriplex ................................... 2
`
`this decision a token of Evonik
`Degussa’s satisfaction with the work
`we have performed so far within the
`Danish pharma industry. For Alsiano,
`the addition of Evonik-Degussa’s
`AEROSIL® line of free flowing agents
`will make our product portfolio vis-à-
`vis our Swedish customers more com-
`plete and thus more attractive”.
`
`The AEROSIL® product portfolio con-
`sists of hydrophobic and hydrophilic
`fumed silica, mixed oxides, metal ox-
`ides and dispersions. For pharmaceu-
`tical manufactures, the AEROSIL® pro-
`duct line also includes hydrophilic and
`hydrophilic colloidal silica pharmaceu-
`tical grades. Evonik-Degussa offers
`technical service laboratories, techni-
`cal support, highly detailed specialist
`literature, and consistency of quality
`and secure supply of products.
`
`Evonik Degussa’s AEROSIL® products
`are stored at Alsiano’s warehouse
`guaranteeing a prompt
`delivery service.
`
`SEPINEOTM - improves
`and simplifies formulation
`of topical emulsions
`and gels .................................. 4
`
`CardiaBeatTM - a fresh
`approach to Omega-3
`and plant Sterol Esters .......... 5
`
`Coming up: Alsiano
`Pharma Seminar 2008 ............ 6
`
`50 years with ingredients
`and raw materials .................. 7
`
`The trendy Ayurveda ............. 7
`
`Lactium® - a natural and
`original slimming
`solution .................................. 8
`
`News in brief ........................ 10
`
`The Alsiano Pharma team ... 10
`
`Publisher: Alsiano A/S
`Circulation: 650 copies
`
`Editor-in-chief:
`Anders Hager
`Coordinator, text, lay-out:
`Dorthe Andersson
`
`Pharma & Healthcare News is
`published twice a year and
`distributed to customers and other
`interested parties. Reproduction
`of articles appearing in Pharma
`& Healthcare News requires prior
`consent of the author. Alsiano is
`not responsible for the content
`of articles written by external
`authors.
`
`By Dorthe Andersson, Marketing,
`Alsiano A/S
`
`We are pleased to announce that
`Evonik Degussa has appointed Alsiano
`as their exclusive distributor in Swe-
`den for their AEROSIL® line of free flow-
`ing agents to the pharmaceutical and
`healthcare industries.
`
`Alsiano has represented Evonik
`Degussa on the Danish market for
`many years, and in future Alsiano will
`also be in charge of introducing the
`AEROSIL® products to the pharmaceu-
`tical and healthcare industries in Swe-
`den.
`
`Glen Marston, sales manager for
`Evonik Degussa’s AEROSIL® line, has
`the following comments to this change
`of organisation: “In our experience,
`working with the pharmaceutical in-
`dustry requires, among other things,
`long term commitment, technical com-
`petence and a thorough under-
`standing of the development
`process in the industry. By
`appointing Alsiano in
`Sweden, we strongly
`believe that Evonik-
`Degussa shall be
`able to meet
`these demands.”
`
`Anders Hager,
`sales manager
`of Alsiano Pharma,
`is pleased with
`Evonik Degussa’s
`decision and sta-
`tes, “We are very
`very proud that
`Evonik Degussa
`has chosen us to
`represent them
`in Sweden and
`consider this
`
`1
`
`AMN1059
`Amneal v. Almirall, LLC
`IPR2018-00608
`
`

`

`Pharma & Healthcare News
`
`No. 7 (cid:127) December 2007
`
`Alsiano
`
`Healthy South African plant extracts from
`Afriplex
`Alsiano has entered into co-operation with Afriplex, South African producer
`of plant extracts, flavours and herbal teas from Africa´s indigenous plants.
`Their wide selection of products includes, among others, fruit pulp from the
`“superfruit” Baobab and extracts from Devil’s Claw, Roiboos and Kigelia – all
`products which can be used in a broad range of applications such as health
`supplements, nutritional bars, skin care products and health drinks
`
`Africa for fever, rheuma-
`toid arthritis and kidney
`problems. Today, the pri-
`mary use of Devil´s Claw
`is for reducing pain and
`swelling of Arthritis pa-
`tients. Joints are situated
`where two bones meet,
`such as elbow and knee.
`Over time, the joint can be-
`come severely damaged.
`
`The main component in
`Devil´s Claw is Harpago-
`side which is a cinnamic es-
`ter. Several clinical studies
`show that Devil’s Claw can
`relieve pain due to its abil-
`ity to reduce inflammation.
`Two studies have been pub-
`lished in Joint Bone Spine
`and European Journal of Anaesthe-
`giology - both studies were placebo-
`controlled and included 122 humans
`and 197 humans respectively.
`
`Devil´s Claw can be combined with
`other anti-inflammatory ingredients
`such as rosehip or ginger from Vidya
`Herbs. Please contact Alsiano for fur-
`ther information.
`
` continues >>
`
`Baobab amino acid content
`Proline
`2.35 g
`Histidine
`2.71 g
`Leucine
`8.4 1 mg
`Arginine
`6.04 g
`Isoleucin
`10.70 g
`Methionine
`4.92 g
`Cystine
`11.23 g
`Phenylalanine
`4.11 g
`Glutamic acid
`4.02 g
`Valine
`1.64 g
`Tyrosine
`4.21 g
`Tryptophane
`1.49 g
`Theronine
`2.96 g
`
`per 100 g
`
`Baobab
`
`Devil’s Claw
`
`Kigelia
`
`Roiboos
`
`By Annette Strarup, Area Sales
`Manager, Alsiano A/S
`
`The increasing demand for
`new superfruits, exotic ex-
`tracts and new antioxidants
`has initiated Alsiano´s decision
`to offer products from Afri-
`plex. Afriplex is an innovative
`company situated in Paarl,
`Cape Town in South Africa.
`Afriplex is cost-effective, and
`at the same time it has an
`inherent responsibility for the
`environment. Below is a brief
`presentation of a selection of
`the interesting products from
`Afriplex.
`
`Baobab fruit pulp:
`Pectin & amino acids in
`natural form
`Numerous studies on the benefits of
`Baobab have been conducted the last
`six years at universities and labora-
`tories. Baobab is a “superfruit” and is
`very close to receive EU Novel Food
`Approval, which has only been granted
`to very few novel foods and exotic
`fruits introduced into the EU due to
`the high cost of getting approval for
`food.
`
`Baobab is recommended for a broad
`range of applications including skin
`supplements (beauty from within),
`intestine health supplements, energy
`drinks (energy booster for athletics)
`and for cereal bars, cookies and
`yoghurts due to its ability to improve
`intestinal health.
`
`Baobab is rich in amino acids (see
`table), it has high concentrations of
`
`bioflavonoids, and a high concentration
`of linolenic acid (omega 3, 6 and 9).
`Further, it is rich in pectin fibre and
`has prebiotic-like activity in-vitro. A
`recently published analysis has
`revealed the level to range between
`23.4 g and 33.8 g pectin/100 g of
`Baobab fruit pulp.
`
`A nutritional analysis of Baobab fruit
`pulp has shown that the fruit is an
`excellent source of calcium and
`vitamin C. In fact, the vitamin C
`content is three times higher than that
`of oranges
`(300 mg/g). The
`antioxidant power of Baobab pulp is
`approx. four times that of kiwi and
`apple pulp.
`
`Devil’s Claw – Cinnamic esters
`for bone & joint health
`Traditionally, Devil´s Claw has been
`used for thousands of years in South
`
`2
`
`

`

`Pharma & Healthcare News
`
`No. 7 (cid:127) December 2007
`
`Alsiano
`
`Name of extract
`
`Botanical name
`
`Active
`
`Baobab Pulp
`
`Adonsonia digitata
`
`Pectin
`Amino acids
`Polyphenols
`Vitamin C
`
`Devil´s Claw
`
`Harpaghytum procumbens
`
`Harpagoside
`
`Rooibos /
`Green Rooibos
`
`Aspalathus linearis
`
`Asphilithin
`
`Kigelia
`
`Kigelia africana
`
`Steroidal saponins
`
`Examples of healthy drinks with Rooibos
`
`Rooibos Extract – Powerful
`anti-oxidant & skin nutrient for
`blemish control
`Rooibos extract - also known as South
`African red tea extract - contains a
`high level of different anti-oxidants
`(including Superoxide Dismutase) and
`a high level of asphilithin, which is
`known for its anti-allergic properties.
`The plant is traditionally used for skin
`conditions to treat dry skin, allergic
`skin, irritated skin and acne. The
`research within Rooibos extract is
`growing and several research teams
`including universities in Japan and
`South Africa are at present conducting
`research about the health promoting
`properties of the ingredient.
`
`The extract is also available in an
`organic version. The latest variant is
`an unfermented version, Novel-T
`Green Rooibos extract, with a higher
`amount of aspilithin. Together with
`Rooibos flavour it is extremely popular
`in the US and Japan within the healthy
`beverage sector for products like ice
`teas, fruit juices, carbonated soft drinks
`and flavoured mineral water.
`
`For blemish control supplements,
`roiboos extract is recommended
`together with dandelion extract,
`silymarin extract, nettle extract and
`burdock extract. For topical applica-
`tions, Rooibos extract is recommended
`together with Sepicontrol A5 (vectori-
`zed amino acid and cinnamon extract)
`from Seppic and/or Kigelia extract
`(read more about Kigelia below).
`
`Kigelia fruit extract – Sun care
`Kigelia extract is produced from the
`seed pod of the “Sausage tree” or the
`Kigelia africana tree. It is traditionally
`used for topical applications and is used
`to ensure a clear, blemish-free
`complexion, for dry skin and skin with
`fungal infection and also in antiaging
`supplements.Scientific literature
`confirms the validity of many of the
`traditional uses due to the presence
`of numerous secondary metabolites
`including iridoids, flavonoids, fatty
`acids and sterols. The sterols
`(phytosterols) are recognized for their
`skin firming abilities and inflammatory
`properties against eczema and other
`skin conditions. They are also used for
`allergy relief.
`
`Other products in Afriplex’s range
`
`Honey bush extract
`
`Rooibos flavor
`
`Aloe Ferox extract
`
`Green fig flavour
`
`Marula flavour
`
`Hoodia powder
`
`Honey bush flavour
`
`Sutherland extract
`
`White wine flavour
`
`Pelargonium extract
`
`Red wine flavour
`
`Recent studies show proven efficacy
`in treating sun induced skin sores, and
`research is currently taking place at
`Freiberg University. Kigelia extract is
`recommended together with melon
`SOD extract (Extramel C from Seppic)
`for sun protection. For anti-age skin
`creams, collagen biosynthesis Kigelia
`extract is recommended together with
`Beta (1.3)-glycan and arginine (please
`contact Alsiano
`for
`further
`information).
`
`Afriplex competencies
`• R&D focused – Afriplex has estab-
`lished partnerships with leading uni-
`versities to facilitate collaborative re-
`search and development of products
`derived from Southern African plants.
`Further, they undertake research
`projects with a number of highly re-
`garded institutions.
`• Creative centre (application lab)
`– In Paarl, South Africa, the AFF Crea-
`tive Centre is situated with focus on
`product innovation and customer ser-
`vice. Afriplex has fully equipped ap-
`plication labs for a wide range of food
`and beverage applications (e.g. bev-
`erages, smoothies, breakfast cereals etc.).
`• Experimental farm – Afriplex has
`invested in the propagation and clon-
`ing of different plant species and con-
`duct tests in a fully-automated green-
`house.
`• Product development – Afriplex has
`expertise in tailoring products by utilizing
`engineering and separation technology.
`
`Article 323
`
`3
`
`

`

`Pharma & Healthcare News
`Food News
`
`No. 7 (cid:127) December 2007
`No. 1 (cid:127) February 2004
`
`Alsiano
`Alsiano
`SEPINEOTM - improves and simplifies formulation
`of topical emulsions and gels
`Seppic launches a new range of excipients dedicated to topical drug
`formulations
`
`By Michel Malandain, Excipients
`Manager & Aude Puget, Market-
`ing & Development, Seppic
`
`In semi-liquid dosage forms, gels and
`emulsions represent two of the most
`widely used topical drug formulations.
`Traditional emulsions used for topical
`applications can be a headache when
`you build your surfactant system using
`a lipophilic plus a hydrophilic sur-
`factant, calculate the HLB of the sys-
`tem and then add a thickener to ob-
`tain consistency. You increase your de-
`velopment step and thereby the cost.
`
`SEPINEOTM
`To improve and simplify formulation,
`SEPPIC proposes SEPINEO™, a new
`range of excipients in pharmaceutical
`grade. SEPINEO™ range means
`excipients dedicated to topical drug
`formulations with SEPPIC pharmaceu-
`tical regulatory support. This range in-
`cludes, for now, a non ionic self-emul-
`sifier, SEPINEO™ SE 68, and a poly-
`mer SEPINEO™ P 600.
`
`SEPINEO™ SE 68 for emulsions
`The SEPINEO™ SE 68 allows the
`manufacture of consistent and stable
`O/W emulsions and avoids the above
`
`enables the formulation of gel or gel-
`cream at room temperature whether
`it includes high shear mixing or not.
`SEPINEO™ P 600 is able to thicken
`formulations over a wide pH range (2
`to 12) with no re-hydratation and no
`neutralisation step. Its compatibility
`with solvents like ethanol, propylene
`glycol, etc. is an advantage that makes
`it possible to elaborate formulas con-
`taining actives with poor solubility (hy-
`dro-alcoholic gels including up to 60%
`ethanol) or water sensible actives (an-
`hydrous formulations).
`
`SEPINEO™ P 600 is also able to emul-
`sify and stabilize many oily phases
`without:
`
`(cid:131)(cid:131)(cid:131)(cid:131)(cid:131) addition of conventional emulsifier
`(cid:131)(cid:131)(cid:131)(cid:131)(cid:131) HLB calculation
`(cid:131)(cid:131)(cid:131)(cid:131)(cid:131) neutralization step
`
` continues >>
`
`About Seppic
`SEPPIC is a supplier of ingredi-
`ents in different business areas
`(industrial, pharmaceutical and
`health care, cosmetics) and a
`subsidiary of AIR LIQUIDE, an in-
`ternational group specialized in
`industrial and medical gases.
`
`SEPPIC offers science and ser-
`vices with highly technical pro-
`duct ranges.
`
`SEPPIC, well known in the phar-
`maceutical area for oral forms,
`does also provide excipients for
`topical forms.
`
`Its expert team enables SEPPIC
`to develop or recommend spe-
`cific formulations accurately tai-
`lored to their customers’ require-
`ments throughout the world.
`
`constraints. It enables to for-
`mulate
`
`(cid:131)
`
`(cid:131)
`
`(cid:131)(cid:131)(cid:131)(cid:131)(cid:131)
`
`(cid:131)(cid:131)(cid:131)(cid:131)(cid:131)
`
`emulsion without thicke-
`ning agent
`
`anhydrous emulsion; for
`water sensitive actives
`
`depending on the nature
`of the oil, O/W stable
`emulsion with high oil
`content (40%: any kind
`of oil / 60% with some
`specific oil)
`
`emulsion with high
`solvent content (30%
`max ethanol in standard
`emulsion)
`
`on
`based
`Emulsions
`SEPINEO™ SE 68 show an
`exceptional stability and viscosity sta-
`bilizes rapidly. These emul-sions have
`pronounced rheo-fluidity and moder-
`ate thixotropic nature, hence favour-
`ing a uniform and homogenous spread-
`ing of the active substances at the skin
`surface. SEPINEO™ SE 68 is able to
`promote liquid crystals, regardless of
`the nature of the fatty phase. This prop-
`erty enables very stable emulsion, pre-
`venting oil droplet coalescence.
`
`SEPINEO™ SE 68 standard dose of use
`is 5%
`
`SEPINEO™ P 600 for gels
`Formulating a gel can also be a head-
`ache when the process requires high
`shear mixing and a neutralisation step
`- it can be hard to avoid a sticky tex-
`ture or a bad behaviour. SEPPIC pro-
`poses a solution to avoid all these
`drawbacks and permit quick develop-
`ments.
`
`SEPINEO™ P 600 is a very-easy-to-
`handle polymer in liquid form that
`gives the opportunity to accelerate
`formulation of pharmaceutical gels. It
`
`4
`
`

`

`Pharma & Healthcare News
`
`No. 7 (cid:127) December 2007
`
`Alsiano
`
`CardiaBeat™ - a fresh approach to Omega-3 &
`plant Sterol Esters
`Omega-3 and plant Sterol Esters enjoy global market awareness during the
`recent years. Enzymotec offers nutraceutical companies an opportunity to
`leverage this ingredient trend by offering additional health benefits with
`CardiaBeat™ - an innovative and unique Sterol/Omega-3 based matrix
`
`The science behind CardiaBeat™
`CVD remains one of the most com-
`mon causes of mortality and morbi-
`dity in developed countries. Lipid man-
`agement, as an important component
`of vascular risk factor control, plays a
`pivotal role in cardiovascular risk fac-
`tor management in all age groups.
`
` continues >>
`
`By Michal Haim-Bravman, Marketing
`Manager, Enzymotec
`
`Omega-3 fatty acids and plant Sterol
`Esters have long been one of the
`strongest market leaders in terms of
`functional, science-based ingredients,
`capable of addressing the specific
`health concern of cardiovascular di-
`seases (CVD). In Scandinavia, the con-
`sumption of these ingredients both in
`the food and dietary supplements
`markets in Scandinavia is one of the
`highest in the world. Although popu-
`lar, one can not ignore some of the
`weaknesses of these popular ingredi-
`ents. Omega-3 fatty acids can have
`intrinsic taste and odor limitations and
`they do also have a certain negative
`impact on HDL and even LDL levels.
`The conventional plant Sterol Esters in-
`hibit the absorption of fat soluble vita-
`mins (beta-carotene), and have not
`shown to have any beneficial impact
`on circulating triglycerides concentra-
`tions. As these ingredients commodi-
`tize, and margins erode, it becomes
`harder for players to take a dominant
`position and to re-invest resources in
`science and thus to enable true differ-
`entiation.
`
`What is CardiaBeat™?
`Is there a way to take these well re-
`cognized ingredients into the next level
`
`of efficacy? Enzymotec, the Israeli bio-
`tech technology company, has laun-
`ched CardiaBeat™ - an innovative and
`unique Sterol/Omega-3 based matrix
`with additional health benefits.
`CardiaBeat™ is an innovative, patent
`protected unique matrix which delivers
`conjugated EPA/DHA Omega-3 fatty
`acids and plant Sterol. This conjuga-
`tion enables lowering the LDL-choles-
`terol and triglycerides
`levels better than fish oil.
`In addition, it ensures
`the optimal vitamin ab-
`sorption, which is a com-
`mon weakness of plant
`sterols. Thus, it offers
`total lipid control for
`CVD patients or individu-
`als at high CVD risk. Fur-
`thermore, Cardia-Beat™
`is a simple and compact
`formula, which enables
`significant and efficient
`dosage of Omega-3 and
`plant Sterols in a rela-
`tively smaller dosage
`form. Lastly, the ingredi-
`ent addresses similar risk
`factors as lipid-lowering
`drugs but through a dif-
`ferent mechanism. Thus,
`it can, when consumed
`in combination with
`statins, achieve greater
`effect or make the re-
`duction of daily drug
`consumption possible.
`
`>>
`
`(continued from page 4)
`
`The SEPINEO™ P 600 emulsifies for-
`mulations with a fatty phase content
`up to 35-40% depending on the na-
`ture of the oil. This gives stable for
`mulations with a perfectly uniform ap-
`
`pearance, very pleasant to the touch
`and with a perfect spread on the skin
`owing to its rheological profile.
`SEPINEO™ P 600, thanks to its non-
`thixotropic nature, promotes formula-
`tions that are not disturbed by shear-
`ing procedures. The formula will show
`
`an immediate recovery of the elastic
`structure (and viscosity) after shear
`stress.
`
`SEPINEO™ P 600 recommended dose
`of use is up to 5%
`
`Article 324
`
`5
`
`

`

`Pharma & Healthcare News
`
`No. 7 (cid:127) December 2007
`
`Alsiano
`
`Qualitative summary of effects*
`
`Solution
`
`CardiaBeatTM
`
`Plant Sterol Esters
`
`Daily intake
`
`2.0 g
`
`1.3 g
`
`Omega-3
`
` max 2.0 g
`
`Sum
`
`+7
`
` +3
`
` +2
`
`LDL
`
`++
`
` ++
`
` 0
`
`Total/HDL
`Cholesterol
`
` ++
`
` Triglycerides
`
`+++
`
` ++
`
` 0
`
` 0
`
` ++
`
`effect on
`Beta carotene
`absorption
`
` 0
`
` -
`
` 0
`
`*Demonty L, Chan YM, Pelled D, and Jones PJ. Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am
`J. Clin Nutr. Dec 2006;84(6):1534-1542.
`
`etc), spreads and others. The formula
`consumed at 2g per day delivers 1.6 g
`of conjugated phytosterol-DHA and
`phytosterol-EPA and 330 mg of DHA
`and EPA.
`
`In terms of regulatory approval,
`CardiaBeat™ has gained GRAS and
`NDI approval from the FDA. In addi-
`tion, it has recently (March 2007)
`gained Novel Food approval from the
`EU committee.
`
`CardiaBeat™ was named as the win-
`ner of the NutrAward 2007 for the best
`new ingredient of 2006 recognizing
`the industry’s most innovative ingredi-
`ent, judged on the basis of scientific
`merit, efficacy, safety, innovation,
`market potential and
`ability to increase
`industry credibility.
`
` >>
`
`(continued from page 5)
`
`There are several population groups
`with high CVD risk such as obese pre-
`diabetics and diabetics, and those who
`suffer from metabolic syndrome.
`
`The unique effect, which comes from
`the Omega-3/Sterol conjugation, was
`evaluated in a clinical trial involving
`healthy human subjects by Professor
`Jones at McGill University, Canada.
`[Demonty et al. AmJ.Clin.Nutr Dec
`2006; 84(6): 1534-1542]. In this study,
`hypolipidemic effects were compared
`to supplementation with fish oil or
`plant Sterol Esters of sunflower oil. All
`supplements were administered on top
`of an olive oil based diet and tested in
`a semi-randomized, single-blind, cross-
`over intervention design. The study
`results demonstrated that in compari-
`son with an olive-oil based diet,
`CardiaBeat reduced:
`
`(cid:131)(cid:131)(cid:131)(cid:131)(cid:131)
`
`LDL levels by 6% similar to the plant
`Sterols Esters effect (measured as
`apolipoprotein B concentration)
`
`(cid:131)(cid:131)(cid:131)(cid:131)(cid:131)
`
`fasting triglycerides by 47%
`
`(cid:131)(cid:131)(cid:131)(cid:131)(cid:131) postprandial triglycerides by 42%
`
`Furthermore, in comparison with fish-
`oil consumption, CardiaBeatTM de-
`creased:
`
`(cid:131)(cid:131)(cid:131)(cid:131)(cid:131)
`
`fasting triglycerides by 10%
`(statistical significance)
`
`(cid:131)(cid:131)(cid:131)(cid:131)(cid:131) postprandial triglycerides by 15%
`(statistical significance)
`
`Additionally, results showed a 16%
`increase in plasma beta-carotene le-
`vels in comparison with the conven-
`tional Phytosterol Esters group (report
`in preparation).
`
`CardiaBeat™ - applications
`CardiaBeat™ is available in a variety
`of grades for dietary supplements (for
`soft gels) and functional foods. The
`product is sold in different countries
`such as USA, Norway and Israel and
`will soon be launched in dietary sup-
`plements in several EU countries, In-
`dia, Australia and Korea. Dietary sup-
`plements with CardiaBeat™ con-
`sumed at 2g per day deliver 1.6g of
`conjugated phytosterol-DHA and phy-
`tosterol-EPA (full RDA of phytosterol-
`esters) and up to 650mg of DHA and
`EPA. CardiaBeat™ supplementation
`may be effective for the prevention or
`treatment of CVD, while potentially
`reducing the daily intake levels of li-
`pid-lowering drugs.
`
`For the food industry, CardiaBeat™ is
`applicable in food products such as
`dairy products (yoghurt, dairy drinks,
`
`Coming up: Alsiano Nordic Pharma Seminar 2008
`our suppliers. The programme will
`Mark your calendar! On 1 April
`becomposed in a way so that it will
`2008, Alsiano will hold its bi-
`cater for the interests of both the phar-
`ennial Nordic Pharma seminar
`maceutical as well as the and
`healthcare industries. The seminar will
`be held in central Copenhagen. More
`information will follow in Jan/Feb 2008.
`
`The seminar will offer many interest-
`ing speeches from a broad a range of
`
`
`
`66
`
`Article 325
`
`From the Pharma Seminar 2006.
`
`

`

`Pharma & Healthcare News
`
`No. 7 (cid:127) December 2007
`
`Alsiano
`
`50 years with ingredients and raw materials
`Alsiano celebrates its 50th anniversary
`
`By Dorthe Andersson, Alsiano A/S
`
`This year, it is 50 years ago that
`Alsiano’s founder, Hans Schmidt, es-
`tablished the company as a classic
`agent. The company grew steadily and
`in 1974 Alsiano’s present owner Erik
`Bang Christensen joined the company.
`
`Until the mid 1990ies Alsiano was a
`successful agency company, building
`relations between mostly European
`producers, whom it represented, and
`Danish customers in the food, feed and
`health care sectors.
`
`In 1996 Alsiano decided on a new
`course. This meant first and foremost
`that Alsiano moved its focus from
`merely selling ingredients and raw
`materials to also providing technical
`application support and ingredients
`solutions.
`
`In 1999, Alsiano expanded its territory
`from working exclusively in Denmark
`to also cover Sweden, Norway, Finland
`and Iceland.
`
`Heavy investments were made in re-
`cruiting highly qualified staff with tech-
`nical expertise, and in 2005 a brand
`new research kitchen facility was in-
`augurated.
`
`Along with this shift in role, several
`other initiatives were introduced to the
`customers such as newsletters, semi-
`nars and travel arrangements in con-
`nection with the now biannual Food
`Ingredients Europe exhibition - all ini-
`tiatives which are still in place.
`
`Alsiano’s 50th anniversary was ce-
`lebrated this summer with an event
`for the company’s employees.
`
`Alsiano held a teambuilding event on a
`schooner to celebrate its anniversary. This
`photo was taken by a daredevil from the
`Food team!
`
`The trendy Ayurveda
`These days when wellness, relaxation, and alternative medicine are hot top-
`ics, Ayurveda is one of the buzz words. But what is Ayurveda?
`
`By Annette Strarup, Area Sales
`Manager, Alsiano A/S
`
`Ayurveda literally means “science of
`life and longevity” and is considered
`to be the traditional system of medi-
`cine of India. Ayurveda is a science in
`the sense that it is a complete system.
`It is a qualitative, holistic science of
`
`health and longevity – a philosophy
`and system of healing the whole per-
`son, body and mind.
`
`The origin of this system goes back to
`times long past when philosophy and
`medicine were not separated. Therefore,
`philosophical views have strongly in-
`fluenced the Ayurvedic way of thinking.
`
`The uniqueness of Ayurveda
`Ayurveda offers reference points for
`managing treatment decisions specific
`to each case. The ayurvedic theory is
`profoundly useful in analysing indivi-
`dual patient constitution and under-
`standing variations in disease manifes-
`tation.
`
`The Ayurvedic framework can be used
`to structure working models of the uni-
`que state of each patient and to pro-
`ject a vision or goal for a whole state
`
`of health - again unique to each case.
`Ayurveda offers specific recommenda-
`tions to each individual on lifestyle,
`diet, exercise and yoga, herbal therapy,
`and even spiritual practices to restore
`and maintain balance in body and
`mind. According to Ayurveda there is
`a strong connection between the mind
`and the body.
`
`Origin of Ayurveda
`Historians have not pin-pointed the
`exact time Ayurveda when came into
`being. Most of them agree, however,
`that Ayurvedic classical texts were
`written in India between3,500 and
`5,000 years ago, though some suggest
`an even longer history.
`
`Producer of extracts, Vidya Herbs, spe-
`cializes in plant extracts used in the
`Ayurveda health system – please con-
`tact Alsiano for more information.
`
`7
`
`

`

`Pharma & Healthcare News
`
`No. 7 (cid:127) December 2007
`
`Alsiano
`
`Lactium® – a natural and original slimming solution
`Lactium® can contribute efficiently to control body weight by helping to support
`the diet. The consumption of Lactium® allows to better manage stress and
`contributes to limit nibbling away (snacking) – notably sweet compulsions.
`Further, it makes it possible to limit food consumption during a diet period
`since it helps to better overcome the stress related to being on a diet
`Lactium®: an efficient help to
`By Sandrine Cuisenier Marketing Man-
`Paul Lattimore2, specialist of nutrition
`ager Ingredia Nutritional
`behaviour in the Liverpool John Moore
`reduce stress effects
`University. The reason why people on
`Lactium®, a milk protein hydrolysate,
`a diet eat more, when they are under
`has during several pre-clinical and clini-
`stress is: ‘’Subjects on a diet devote a
`cal studies proved its efficiency to regu-
`considerable energy to control their
`late stress symptoms without side ef-
`biological trends, so that they have limi-
`fects. This efficiency was acknow-
`ledged by the authorities - no-
`tably AFSSA – who granted
`that Lactium®: “Can reduce
`the tensional response to
`stress, notably among persons
`who are particularly sensitive
`to it”.
`
`Scientific knowledge: Stress
`& weight gain
`Today, the scientific community recog-
`nizes the link between stress and
`weight gain. After eating
`habits, this is one of the fac-
`tors of overweight, often in
`the shape of nibbling away -
`most of the time at sweet
`products. Over the past 10
`years, more than 30 articles
`have emphasized the positive
`link between stress and
`weight increase. A biblio-
`graphical source is available
`on request.
`
`In stress conditions, nutritious
`behaviour is very much di-
`rectly affected among men
`and women. Subjects seem
`to be tempted to nibbling
`away and more liable to
`choose sweet and fat pro-
`ducts. According to Zellner
`and al (20061), more than
`71% of studied subjects in-
`crease their eating habits
`when they are under stress.
`In this way, stress can have
`a significant implication in the
`obesity epidemic which has
`raged over the past 10 years
`or more. Yet, public health
`messages, now put forward
`in developed countries, talk
`about limiting sugar, fat and
`favouring health foods con-
`sumption, without taking
`into account the factors which predict
`nutrition choices.
`
`Other research has shown that persons
`on a restrictive diet eat more when
`they are under stress. According to
`
`ted resources to face up to stress daily.
`When they are under stress, they lose
`control and if they can, they eat. They
`are so in the habit of thwarting their
`biological signs that they ignore, mis-
`read or fight signs of their system.”
`
`8
`
`Pre-clinical and clinical
`studies
`To prove the interest of
`Lactium® in a slimming pro-
`duct, various pre-clinical and
`clinical studies have been con-
`ducted. Here are the findings:
`
`Clinical study PROCLAIM
`(2003): The study was con-
`ducted on 63 women and
`based on a double-blind, pla-
`cebo-controlled, cross-over
`design with a 150 mg/day do-
`sage of the active. Using a
`questionnaire, the subjects re-
`ported on the improvements
`felt for each stress symptom.
`There were 8 categories of
`types of symptoms. A signifi-
`cant positive influence on
`stress symptoms was observed
`in each of the eight groups
`when Lactium® was compared
`to the placebo group. On
`weight disorders, the improve-
`ment was 42% (see figure 1 and 2).
`continues >>
`
`1 Zellner DA, Loaiza S, Gonzalez Z, Pita J, Morales J,
`Pecora D, Wolf A. Physiol Behav. 2006 Apr
`2 Lattimore, SFN Cahiers de la nutrition et diététique
`volume 40 dic. 2005
`
`

`

`Pharma & Healthcare News
`
`No. 7 (cid:127) December 2007
`
`Alsiano
`
`Lactium® can be your
`ideal partner for slim-
`ming by acting 2 ways:
`
`- By limiting snacking,
`particularly
`sweet
`foods, due to stress
`
`- By helping to resist
`during a stressful diet
`period to not break up
`and thus avoid the
`“yoyo effect”.
`
`regularly put on the
`market. Nutritionists
`note that a great major-
`ity of people have or will
`have an overweight
`problem sometime dur-
`ing their life. Therefore,
`the need for low fat, low
`sugar and low calories
`foods is still huge.
`Moreover, consumers
`are looking for an effi-
`cient solution to their overweight prob-
`lem. One of these solutions is to regu-
`late stress, which is known as having
`an adverse impact on weight manage-
`ment.
`
`Whereas medical solutions have un-
`desirable side effects, Lactium® is an
`efficient solution. Used in functional
`foods such as beverages, dairy prod-
`ucts, or in dietetics products as meal
`substitute or in dietary supplements,
`Lactium® is a valuable solution to over-
`weight problems due to stress.
`
`With Lactium®, we offer you an origi-
`nal positioning on the competitive slim-
`ming market. Used alone as in the
`‘’Zen&Slim’’ concept - ’for a diet with-
`out snacking or bad mood’’ - or in com-
`plement with a slimming active (e.g.
`an active limiting the carbohydrates
`absorption) as in the ‘’Banana Breeze’’
`concept‘’ – “lighten up with this deli-
`cious new drink that may assist you in
`weight control and improve your
`mood.’’
`Article 326
`
`Figure 2: Proclaim Study 2003
`
`Lactium improvement %
`
`Lactium/placebo improvement %
`
`Weight
`symptoms
`
`“You have
`problems of
`appetite”
`
`Influence of stress on sweet nib-
`bling (Jan 2007): A rat study from
`January 2007 shows that during a
`moderate stress period, the nutrition
`behaviour of the rat creates unbalance,
`because it prioritizes the sweet solu-
`tions taken at the expense of stand-
`ard food. On the other hand, the
`stressed rat, who has been given
`Lactium®, limits qualitatively his food
`intake at the same level as a rat that
`is not under stress (reference). Conse-
`quently, the percentage of fat mass
`increasing strongly evolves among
`stressed rats, even though it stays sta-
`ble and similar to the reference group
`for stressed rats that have taken
`Lactium®. Lactium® regulates the food
`intake during a stressful period and lim-
`its sweet nibbling.
`
`LACTIUM® - your partner for
`slimming and body weight
`control
`Slimming is a huge trendy market and
`a lot of innovations in this field are
`
`Figure 1: Proclaim Study 2003
`Stress symptoms improvement Lactium/
`placebo improvement %
`
`Tensional state +37%
`
`Physical pain +54%
`
`Memory & concentration +46%
`
`Sleep +21%
`
`Mood +74%
`
`“You gain
`or lose
`weight”

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket